| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |